Brief Psychological Intervention for Suicidal Patients With Borderline Personality Disorder in the Emergency Department
Randomized Controlled Trial of a Brief Psychological Intervention for Suicidal Patients With Borderline Personality Disorder in the Emergency Department
1 other identifier
interventional
180
1 country
1
Brief Summary
When in crisis, people with borderline personality disorder (BPD) frequently seek care in emergency departments (EDs) often presenting with suicide and self-harm behaviour. There is no established evidence-based brief treatment for patients with BPD in ED settings, however a 4-session treatment for people with personality disorders in ED settings was tested in Australia and showed promising results in reducing health care use and improving symptoms. A recent pilot feasibility randomized controlled trial (RCT) comparing this 4-session treatment to treatment as usual was conducted at the Centre for Addiction and Mental Health and preliminary findings have shown that the treatment is feasible to deliver and acceptable to both patients and clinicians. The proposed fully powered RCT will build on this pilot data to assess the efficacy of delivering this 4-session intervention in the ED for people with BPD who present with suicidal ideation or self-harm with the aim of reducing emergency health care use and improving BPD symptoms, functioning and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2024
CompletedFirst Posted
Study publicly available on registry
November 5, 2024
CompletedStudy Start
First participant enrolled
December 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
February 11, 2026
February 1, 2026
2.6 years
November 4, 2024
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Suicidal Ideation
Suicidal Ideation Attributes Scale (SIDAS): is a self-report questionnaire that assesses history and severity of suicidal behaviour and ideation. Scores range from 0-50 with lower scores indicating less suicidal ideation.
6 Month Follow Up
Secondary Outcomes (8)
Suicidal Ideation
3 Month Follow Up
Health Care Use
3 and 6 Month Follow Up
Borderline Personality Disorder Symptoms
3 and 6 Month Follow Up
Self-Harm Behavior
3 and 6 Month Follow Up
Emotion Regulation
3 and 6 Month Follow Up
- +3 more secondary outcomes
Study Arms (2)
Treatment As Usual
ACTIVE COMPARATORAccess to psychiatric assessment, medication review, and unscheduled sessions with allied health professionals using a drop-in model of care.
Gold Card Intervention
EXPERIMENTALA 4-session manualized intervention consisting of weekly scheduled 50-minute 1:1 sessions focused on psycho-education, here-and-now problem solving and safety planning. One of the sessions can involve a significant other to provide psychoeducation about the disorder and to facilitate support.
Interventions
A 4-session manualized intervention consisting of weekly scheduled 50-minute 1:1 sessions focused on psycho-education, here-and-now problem solving and safety planning. One of the sessions can involve a significant other to provide psychoeducation about the disorder and to facilitate support.
Access to psychiatric assessment, medication review, and unscheduled sessions with allied health professionals using a drop-in model of care.
Eligibility Criteria
You may qualify if:
- Must be deemed to have capacity to provide informed consent;
- Must sign and date the informed consent form;
- Stated willingness to comply with all study procedures;
- Aged 16 or older;
- Presenting to ED with self-harm and/or suicidal ideation;
- Meeting criteria for BPD on the International Personality Disorders Examination (IPDE).
- Endorsing a score of 1 or greater on the Suicide Ideation Attributes Scale (SIDAS).
You may not qualify if:
- Meeting DSM-5 criteria for schizophrenia spectrum disorder or bipolar disorder I mania based on the Structured Clinical Interview for DSM-5 (SCID-5);
- Severe alcohol or substance use disorder based on the Structured Clinical Interview for DSM-5 (SCID-5) requiring medical detoxification or residential treatment.
- IQ \< 70 based on the Test of Premorbid Functioning (TOPF).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Addiction and Mental Health
Toronto, Ontario, M6J1H4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Statistician
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated Scientist
Study Record Dates
First Submitted
November 4, 2024
First Posted
November 5, 2024
Study Start
December 12, 2024
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
February 11, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share